Mark Stevenson
Chief Operating Officer
What are current trends in the life sciences and how is Life Technologies addressing them?
The growing importance of applied markets is a trend across the life sciences space and is an area of significant focus at Life Technologies. Our line of DNA forensic testing products have been market leaders since that field's inception and we also offer genetic testing products for food safety and animal health applications.
We are expanding our footprint in the clinical diagnostics space and translational medical research, helping to bridge the gap between academic discovery and delivering truly individualized medicine to patients in the community hospital setting.
Where do you see your company's growth?
Life Technologies is a trusted scientific partner and collaborator to our customers. We believe that exhibiting true thought leadership in our space and not simply functioning as a provider of products has been key to our success and will continue to be fundamental as we move forward.
We have also for the last several years maintained a laser focus on emerging markets. As science grows at a rapid pace in the developing world, particularly in China and India, we will continue to grow our presence in these countries as well.
LIFE TECHNOLOGIES CORP. is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences.
With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum, scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research.
Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies Corp. was formed in 2008 with the merger of Invitrogen Corporation and Applied Biosystems Inc. The company elected to take the name Life Technologies, which was a trademark held by Invitrogen as a result of a prior acquisition.
The company is currently in the process of being acquired by Thermo Fisher Scientific.
Chief Operating Officer
What are current trends in the life sciences and how is Life Technologies addressing them?
The growing importance of applied markets is a trend across the life sciences space and is an area of significant focus at Life Technologies. Our line of DNA forensic testing products have been market leaders since that field's inception and we also offer genetic testing products for food safety and animal health applications.
We are expanding our footprint in the clinical diagnostics space and translational medical research, helping to bridge the gap between academic discovery and delivering truly individualized medicine to patients in the community hospital setting.
Where do you see your company's growth?
Life Technologies is a trusted scientific partner and collaborator to our customers. We believe that exhibiting true thought leadership in our space and not simply functioning as a provider of products has been key to our success and will continue to be fundamental as we move forward.
We have also for the last several years maintained a laser focus on emerging markets. As science grows at a rapid pace in the developing world, particularly in China and India, we will continue to grow our presence in these countries as well.
LIFE TECHNOLOGIES CORP. is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences.
With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum, scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research.
Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies Corp. was formed in 2008 with the merger of Invitrogen Corporation and Applied Biosystems Inc. The company elected to take the name Life Technologies, which was a trademark held by Invitrogen as a result of a prior acquisition.
The company is currently in the process of being acquired by Thermo Fisher Scientific.